Skip to content

To compare the diagnostic efficiency and the impact on the overall prognosis of balloon-assisted enteroscopy and capsule endoscopy as the first-line examination in patients with overt suspected small intestinal bleeding: a prospective randomized controlled trial

To compare the diagnostic efficiency and the impact on the overall prognosis of balloon-assisted enteroscopy and capsule endoscopy as the first-line examination in patients with overt suspected small intestinal bleeding: a prospective randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077574
Enrollment
Unknown
Registered
2023-11-13
Start date
2023-11-15
Completion date
Unknown
Last updated
2023-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

overt suspected small bowel bleeding

Interventions

Capsule Endoscopy Group:Capsule endoscopy (either magnetically controlled or conventional) of the small intestine was performed within 48 hours after enrollment
Balloon-assisted enteroscopy group:Balloon-assisted enteroscopy were completed within 48 hours of enrollment

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 99 Years

Inclusion criteria

Inclusion criteria: The following criteria must also be met (1) Melena and/or hematochezia within 24 hours (2) No suspicious bleeding lesions were found by esophagogastroduodenoscopy, colonoscopic examination and abdominal CT

Exclusion criteria

Exclusion criteria: Exclusion was required if any of the following criteria were met (1) No informed consent was obtained (2) currently pregnant or lactating (3) suspected or known gastrointestinal obstruction, stenosis, sinus formation, or dysphagia (4) refusing or not qualified for surgery (5) hemodynamic instability, such as shock (6) Currently participating in other clinical studies

Design outcomes

Primary

MeasureTime frame
Diagnostic yield of lesion;

Secondary

MeasureTime frame
Rebleeding rate at 3 months;Length of stay;Volume of blood transfusion;Further endoscopic/interventional/surgical intervention rates;

Countries

China

Contacts

Public ContactXue Xiao

Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University

xxuenk@gmail.com+86 159 8217 5701

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026